Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,461 to 1,480 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01CA178063 | Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma | 1 | 2018 |
| R01CA179044 | Identification and modeling of driver genetic modules in glioblastoma | 1 | 2018 |
| R01CA181355 | Investigating and Targeting TAMs in the Glioma Microenvironment | 1 | 2018 |
| R01CA181808 | Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis | 1 | 2018 |
| R01CA187076 | The role of the PI3K pathway in immune resistance | 1 | 2018 |
| R01DA037843 | Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation | 1 | 2018 |
| R01DK041526 | Tumor necrosis factor superfamily of ligands and receptors in progressive renal decline in diabetes | 1 | 2018 |
| R01DK047297 | Role of Eicosanoids in Intestinal Biology | 1 | 2018 |
| R01EB005678 | Controlled Release Scaffolds for Nerve Regeneration | 1 | 2018 |
| R01EB009910 | Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy | 1 | 2018 |
| R01EB013198 | Antigen loaded particles for tolerance induction | 1 | 2018 |
| R01ES012974 | Epigenetic Transgenerational Endocrine Disruptor Actions | 1 | 2018 |
| R01EY016813 | REACTIVE INTERMEDIATES OF OXIDATIVE LIPID FRAGMENTATION | 1 | 2018 |
| R01EY025225 | Mechanism-based therapies for photoreceptor degeneration | 1 | 2018 |
| R01GM024211 | Corticosteroid Pharmacokinetics and Pharmacodynamics | 1 | 2018 |
| R01GM112945 | Integrative informatics approach to develop safe glucocorticoid therapies | 1 | 2018 |
| R01GM114267 | Integrative Visual and Computational Exploratory Analysis of Genomics Data | 1 | 2018 |
| R01HL075360 | Systems Biology of Macrophage Polarizaiton Following Myocardial Infarction | 1 | 2018 |
| R01HL122068 | Targeting beta-arrestins in Pulmonary Fibrosis | 1 | 2018 |
| R01HL122712 | Mendelian Disease - Asthma Comorbidity to Find Subgroup-Specific Asthma Genes | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=74